These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 14529314)
21. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome. Hammer S; Dorrani N; Dragich J; Kudo S; Schanen C Ment Retard Dev Disabil Res Rev; 2002; 8(2):94-8. PubMed ID: 12112734 [TBL] [Abstract][Full Text] [Related]
22. De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Kleefstra T; Yntema HG; Oudakker AR; Romein T; Sistermans E; Nillessen W; van Bokhoven H; de Vries BB; Hamel BC Clin Genet; 2002 May; 61(5):359-62. PubMed ID: 12081720 [TBL] [Abstract][Full Text] [Related]
23. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Miltenberger-Miltenyi G; Laccone F Hum Mutat; 2003 Aug; 22(2):107-15. PubMed ID: 12872250 [TBL] [Abstract][Full Text] [Related]
24. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. Buschdorf JP; Strätling WH J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241 [TBL] [Abstract][Full Text] [Related]
25. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735 [TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Beyer KS; Blasi F; Bacchelli E; Klauck SM; Maestrini E; Poustka A; Hum Genet; 2002 Oct; 111(4-5):305-9. PubMed ID: 12384770 [TBL] [Abstract][Full Text] [Related]
27. Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease. Villard L; Lévy N; Xiang F; Kpebe A; Labelle V; Chevillard C; Zhang Z; Schwartz CE; Tardieu M; Chelly J; Anvret M; Fontès M J Med Genet; 2001 Jul; 38(7):435-42. PubMed ID: 11432961 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318 [TBL] [Abstract][Full Text] [Related]
29. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Shahbazian MD; Zoghbi HY Curr Opin Neurol; 2001 Apr; 14(2):171-6. PubMed ID: 11262731 [TBL] [Abstract][Full Text] [Related]
30. Rett syndrome in a 47,XXX patient with a de novo MECP2 mutation. Hammer S; Dorrani N; Hartiala J; Stein S; Schanen NC Am J Med Genet A; 2003 Oct; 122A(3):223-6. PubMed ID: 12966522 [TBL] [Abstract][Full Text] [Related]
31. MECP2 mutation screening in Swedish classical Rett syndrome females. Erlandson A; Hallberg B; Hagberg B; Wahlström J; Martinsson T Eur Child Adolesc Psychiatry; 2001 Jun; 10(2):117-21. PubMed ID: 11469283 [TBL] [Abstract][Full Text] [Related]
32. Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia. Chen CH; Cheng MC; Huang A; Hu TM; Ping LY; Chang YS Front Genet; 2020; 11():476. PubMed ID: 32457807 [TBL] [Abstract][Full Text] [Related]
33. Denaturing high-performance liquid chromatography and sequence analyses for MECP2 mutations in Rett syndrome. Buyse IM; Roa BB Methods Mol Biol; 2003; 217():119-30. PubMed ID: 12491927 [No Abstract] [Full Text] [Related]
34. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Amir RE; Zoghbi HY Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222 [TBL] [Abstract][Full Text] [Related]
35. MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Shibayama A; Cook EH; Feng J; Glanzmann C; Yan J; Craddock N; Jones IR; Goldman D; Heston LL; Sommer SS Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):50-3. PubMed ID: 15211631 [TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of Japanese patients with Rett syndrome: Identification of five novel mutations and genotype-phenotype correlation. Yamada Y; Miura K; Kumagai T; Hayakawa C; Miyazaki S; Matsumoto A; Kurosawa K; Nomura N; Taniguchi H; Sonta SI; Yamanaka T; Wakamatsu N Hum Mutat; 2001 Sep; 18(3):253. PubMed ID: 11524741 [TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome. Amano K; Nomura Y; Segawa M; Yamakawa K J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854 [TBL] [Abstract][Full Text] [Related]
38. [Epigenetic study of Rett's syndrome as an adequate model for autistic disorders]. Iurov IIu; Vorsanova SG; Voinova-Ulas VIu; Villard L; Demidova IA; Giunti L; Guivabyccu-Uzielli ML; Budilov AV; Beresheva AK; Novikov PV; Iurov IuV Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):4-11. PubMed ID: 16117140 [TBL] [Abstract][Full Text] [Related]
39. Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation. Dotti MT; Guideri F; Acampa M; Orrico A; Battisti C; Federico A J Child Neurol; 2004 Dec; 19(12):964-6. PubMed ID: 15704871 [TBL] [Abstract][Full Text] [Related]
40. Spectrum of MECP2 mutations in Rett syndrome. Lee SS; Wan M; Francke U Brain Dev; 2001 Dec; 23 Suppl 1():S138-43. PubMed ID: 11738860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]